Diagnostics-as-a-service may be one of the most important opportunities in digital health

Though often underappreciated, lab tests inform 70% of today’s medical decisions. In fact, they’re some of the best tools available to identify health risks, pinpoint diagnoses, plan treatments, and monitor conditions over time.

Compared to many other segments of healthcare, however, the lab testing industrial complex has received disproportionately less attention and investment, causing it to fall markedly behind on the digitalization and consumerization initiatives sweeping the rest of the industry. It’s one of the reasons why we at OMERS Ventures are tracking the space closely.

On top of that, forward momentum has long been stifled by the presence of a major duopoly that, at times, has been accused of predatory practices.